Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving KATP channels

Vascular Pharmacology

Volumn 46, Issue 2, 2007, Pages 129-136

  Iskit, Alper B ^a   Erkent, Ulkem ^a   Ertunc, Mert ^a   Guc, M Oguz ^a   Ilhan, Mustafa ^a   Onur, Rustu ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Arrhythmia; Endotoxin; Glibenclamide; Nateglinide; Nitric oxide; Repaglinide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); CANAVANINE; DEXAMETHASONE; DRUG VEHICLE; ENDOTOXIN; GLIBENCLAMIDE; GLIBORNURIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NATEGLINIDE; POTASSIUM CHANNEL BLOCKING AGENT; REPAGLINIDE; SULFONYLUREA; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE MODEL; DRUG ANTAGONISM; DRUG MECHANISM; ENDOTOXEMIA; ESCHERICHIA COLI; EXTRASYSTOLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPOGLYCEMIA; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; ARRHYTHMIA; BLOOD PRESSURE; CARBAMATES; CYCLOHEXANES; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENDOTOXEMIA; GLYBURIDE; HEART ATRIA; HEART CONDUCTION SYSTEM; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL ISCHEMIA; PHENYLALANINE; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; TACHYCARDIA, VENTRICULAR; TETRAETHYLAMMONIUM; TIME FACTORS; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 33845595473     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.08.415     Document Type: Article

References (37)

1. Bateson A.N., Jakiwczyk O.M., and Schulz R. Rapid increase in inducible nitric oxide synthase gene expression in the heart during endotoxemia. Eur. J. Pharmacol. 303 (1996) 141-144
2. Chen C.C., Lin Y.C., Chen S.A., Luk H.N., Ding P.Y., Chang M.S., and Chiang C.E. Shortening of cardiac action potentials in endotoxic shock in guinea pigs is caused by an increase in nitric oxide activity and activation of the adenosine triphosphate-sensitive potassium channel. Crit. Care Med. 28 6 (2000) 1713-1720
3. Clark C., Foreman M.I., Kane K.A., McDonald F.M., and Parrat J.R. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J. Pharmacol. Methods 3 (1980) 357-368
4. Elliott G.T., Comerford M.L., Smith J.R., and Zhao L. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide. Cardiovasc. Res. 32 6 (1996) 1071-1080
5. El-Reyani N.E., Bozdogan O., Baczko I., Lepran I., and Papp J.G. Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats. Eur. J. Pharmacol. 365 (1999) 187-192
6. Fleming I., Gray G.A., Julou-Schaeffer G., Parratt J.R., and Stoclet J.C. Incubation with endotoxin activates the l-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171 (1990) 562-568
7. Gardiner S.M., Kemp P.A., March J.E., and Bennett T. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol. 116 (1995) 2005-2011
8. Guc, M.O., 1992. Vascular responsiveness to vasoactive agents in endotoxaemia, PhD thesis. University of Strathclyde, Glasgow, United Kingdom.
9. Guc M.O., Boachie-Ansah G., Kane K.A., and Wadsworth R.M. Comparison of antiarrhythmic and electrophysiologic effects of diltiazem and its analogue siratiazem. J. Cardiovasc. Pharmacol. 27 (1993) 681-686
10. Hu S., Wang S., and Dunning B.E. Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels. J. Pharmacol. Exp. Ther. 291 3 (1999) 1372-1379
11. Hung J., and Lew W.Y. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ. Res. 73 (1993) 125-134
12. 2+ concentration of rat pancreatic beta-cells. J. Pharm. Sci. 91 (2003) 41-46
13. Iskit A.B., and Guc M.O. Comparison of sodium pentobarbitone and urethane anaesthesia in a rat model of coronary artery occlusion and reperfusion arrhythmias: interaction with l-NAME. Pharmacol. Res. 33 1 (1996) 13-18
14. Iskit A.B., and Guc M.O. Thimerosal attenuates ischaemia-reperfusion arrhythmias in rats: no modification by antiischaemic agent trimetazidine or endotelin receptor antagonist bosentan. Pharmacol. Res. 34 1-2 (1996) 17-23
15. Iskit A.B., Guc M.O., and Ilhan M. l-canavanine and dexamethasone attenuate endotoxin-induced suppression of ischaemia-reperfusion arrhythmias. Eur. J. Pharmacol. 326 (1997) 183-190
16. Isono T., Sato N., Koibuchi Y., Sakai S., Yamamoto T., Ozaki R., Mori J., Kohsaka M., and Ohtsuka M. Effect of FK409, a novel nitric oxide donor, on acute experimental myocardial ischemia. Jpn. J. Pharmacol. 62 (1993) 315-324
17. Klimes I., Mitkova A., Gasperikova D., Ukropec J., Liska B., Bohov P., Stanek J., and Sebokova E. The effect of the new oral hypoglycemic agent A-4166 on glucose turnover in the high fat diet-induced and/or in the hereditary insulin resistance of rats. Arch. Physiol. Biochem. 106 4 (1998) 325-332
18. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J. Clin. Invest. 89 6 (1992) 2071-2074
19. Lew W.Y., Yasuda S., Yuan T., and Hammond H.K. Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits. J. Mol. Cell. Cardiol. 28 6 (1996) 1367-1371
20. Malaisse W.J. Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus. Treat. Endocrinol. 2 6 (2003) 401-414
21. Nishigaki R., Aramaki T., Hirakawa K., and Asano G. Nitric oxide production and energy state in the heart after endotoxin administration. Jpn. Circ. J. 62 7 (1998) 527-531
22. Parratt J.R., and Szekeres L. Delayed protection of the heart against ischaemia. Trends Pharmacol. Sci. 16 (1995) 351-354
23. + channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 53 (2004) S156-S164
24. 2+-independent nitric oxide synthases. FEBS Lett. 291 (1991) 145-150
25. Schultz J.E., Yao Z., Cavero I., and Gross G.J. Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am. J. Physiol. 272 6 Pt 2 (1997) H2607-H2615
26. 2+ independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105 (1992) 575-580
27. Song W., Furman B.L., and Parratt J.R. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of E. coli endotoxin. Br. J. Pharmacol. 118 (1996) 2157-2161
28. Sorrentino R., d'Emmanuele di Villa Bianca R., Lippolis L., Sorrentino L., Autore G., and Pinto A. Involvement of ATP-sensitive potassium channels in a model of a delayed vascular hyporeactivity induced by lipopolysaccharide in rats. Br. J. Pharmacol. 127 6 (1999) 1447-1453
29. Thompson M., Kliewer A., Maass D., Becker L., White D.J., Bryant D., Arteaga G., Horton J., and Giroir B.P. Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs. Pediatr. Res. 47 5 (2000) 669-676
30. 2+ transients in single ventricular myocytes of the guinea pig. Jpn. J. Pharmacol. 80 3 (1999) 243-253
31. Tracey W.R., Tse J., and Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272 (1995) 1011-1019
32. Vanelli G., Hussain S.N., and Aguggini G. Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig. Exp. Physiol. 80 1 (1995) 167-170
33. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness S.M., Harron D.W.J., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Riemersma R.A., Riva E., Russell D.C., Sheridan D.J., Winslow E., and Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-457
34. Wilson A.J., and Clapp L.H. The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta. Cardiovasc. Res. 56 1 (2002) 154-163
35. Winer B.J. Multifactor experiments having repeated measures on the same elements. In: Winer B.J. (Ed). Statistical Principles in Experimental Design (1972), McGraw-Hill, New York 514
36. Wu C.C., Thiemermann C., and Vane J.R. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br. J. Pharmacol. 114 6 (1995) 1273-1281
37. Zhong J., Hwang T.C., Adams H.R., and Rubin L.J. Reduced l-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am. J. Physiol. 273 (1997) H2312-H2324